RxDoctor Payments Data

Zachary Weinerman, MD

Anesthesiology · Detroit, MINPI 1588125520

Payments from drug & device makers

What this record shows

This record is dominated by grants: $20,000 of the $23,533 with a category attached, or 85.0%. 6 manufacturers reported payments, led by Boston Scientific at 54.4% of the total. Reporting peaked in 2023 at $20,995 and has fallen 97.3% since, to $559 in 2025. Among anesthesiology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,533in general payments, 2019–2025

Across 29 payments — averaging $811.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$13K
  • Medtronic$10K
  • Nevro Corp.$182
  • Globus Medical$170
  • Averitas Pharma Inc.$126
  • Si-bone, Inc.$95

What the payments were for

  • Grants$20,00085%
  • Travel & lodging$1,8318%
  • Food & beverage$1,7027%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific21$12,811
Medtronic2$10,149
Nevro Corp.3$182
Globus Medical1$170
Averitas Pharma Inc.1$126
Si-bone, Inc.1$95

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,533 in reported general payments places this provider in the 95th percentile of 1,299 anesthesiology providers in Michigan.

See all anesthesiology providers in Michigan

Medicare billing

Part B allowed, 2024
$10,047
Medicare patients
78
Services billed
106

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin23$492
Cyclobenzaprine Hcl11$86

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →